These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 15239100)
1. Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver. Ovejero C; Cavard C; Périanin A; Hakvoort T; Vermeulen J; Godard C; Fabre M; Chafey P; Suzuki K; Romagnolo B; Yamagoe S; Perret C Hepatology; 2004 Jul; 40(1):167-76. PubMed ID: 15239100 [TBL] [Abstract][Full Text] [Related]
2. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis. Bhatia N; Spiegelman VS Mol Carcinog; 2005 Apr; 42(4):213-21. PubMed ID: 15765534 [TBL] [Abstract][Full Text] [Related]
3. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. González-Sancho JM; Aguilera O; García JM; Pendás-Franco N; Peña C; Cal S; García de Herreros A; Bonilla F; Muñoz A Oncogene; 2005 Feb; 24(6):1098-103. PubMed ID: 15592505 [TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of a novel human gene, DRCTNNB1A, the expression of which is down-regulated by beta-catenin. Kawasoe T; Furukawa Y; Daigo Y; Nishiwaki T; Ishiguro H; Fujita M; Satoh S; Miwa N; Nagasawa Y; Miyoshi Y; Ogawa M; Nakamura Y Cancer Res; 2000 Jul; 60(13):3354-8. PubMed ID: 10910037 [TBL] [Abstract][Full Text] [Related]
5. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation. Esufali S; Bapat B Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999 [TBL] [Abstract][Full Text] [Related]
7. Identification of MYCBP as a beta-catenin/LEF-1 target using DNA microarray analysis. Jung HC; Kim K Life Sci; 2005 Jul; 77(11):1249-62. PubMed ID: 15979100 [TBL] [Abstract][Full Text] [Related]
8. Beta-catenin/T-cell factor-mediated transcription is modulated by cell density in human bronchial epithelial cells. Steel MD; Puddicombe SM; Hamilton LM; Powell RM; Holloway JW; Holgate ST; Davies DE; Collins JE Int J Biochem Cell Biol; 2005 Jun; 37(6):1281-95. PubMed ID: 15778091 [TBL] [Abstract][Full Text] [Related]
9. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402. Zhao DH; Hong JJ; Guo SY; Yang RL; Yuan J; Wen CY; Zhou KY; Li CJ Cell Res; 2004 Feb; 14(1):74-80. PubMed ID: 15040893 [TBL] [Abstract][Full Text] [Related]
10. Overview of the molecular biology of hepatocellular neoplasms and hepatoblastomas of the mouse liver. Kim Y; Sills RC; Houle CD Toxicol Pathol; 2005; 33(1):175-80. PubMed ID: 15805069 [TBL] [Abstract][Full Text] [Related]
11. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex. Hämmerlein A; Weiske J; Huber O Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065 [TBL] [Abstract][Full Text] [Related]
12. Smad1, beta-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription. Hu MC; Rosenblum ND Development; 2005 Jan; 132(1):215-25. PubMed ID: 15576399 [TBL] [Abstract][Full Text] [Related]
13. Coordinated expression of cyclin D1 and LEF-1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma. Schmitt-Graeff A; Ertelt-Heitzmann V; Allgaier HP; Olschewski M; Nitschke R; Haxelmans S; Koelble K; Behrens J; Blum HE Liver Int; 2005 Aug; 25(4):839-47. PubMed ID: 15998435 [TBL] [Abstract][Full Text] [Related]
14. Wnt/beta-catenin signaling in murine hepatic transit amplifying progenitor cells. Hu M; Kurobe M; Jeong YJ; Fuerer C; Ghole S; Nusse R; Sylvester KG Gastroenterology; 2007 Nov; 133(5):1579-91. PubMed ID: 17983805 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus X protein is essential for the activation of Wnt/beta-catenin signaling in hepatoma cells. Cha MY; Kim CM; Park YM; Ryu WS Hepatology; 2004 Jun; 39(6):1683-93. PubMed ID: 15185310 [TBL] [Abstract][Full Text] [Related]
16. STMN2 is a novel target of beta-catenin/TCF-mediated transcription in human hepatoma cells. Lee HS; Lee DC; Park MH; Yang SJ; Lee JJ; Kim DM; Jang Y; Lee JH; Choi JY; Kang YK; Kim DI; Park KC; Kim SY; Yoo HS; Choi EJ; Yeom YI Biochem Biophys Res Commun; 2006 Jul; 345(3):1059-67. PubMed ID: 16712787 [TBL] [Abstract][Full Text] [Related]
17. Tbx3 is a downstream target of the Wnt/beta-catenin pathway and a critical mediator of beta-catenin survival functions in liver cancer. Renard CA; Labalette C; Armengol C; Cougot D; Wei Y; Cairo S; Pineau P; Neuveut C; de Reyniès A; Dejean A; Perret C; Buendia MA Cancer Res; 2007 Feb; 67(3):901-10. PubMed ID: 17283120 [TBL] [Abstract][Full Text] [Related]
18. Wnt and beta-catenin signaling target the expression of ecto-5'-nucleotidase and increase extracellular adenosine generation. Spychala J; Kitajewski J Exp Cell Res; 2004 Jun; 296(2):99-108. PubMed ID: 15149841 [TBL] [Abstract][Full Text] [Related]
19. Novel candidate targets of Wnt/beta-catenin signaling in hepatoma cells. Lee HS; Park MH; Yang SJ; Park KC; Kim NS; Kim YS; Kim DI; Yoo HS; Choi EJ; Yeom YI Life Sci; 2007 Jan; 80(7):690-8. PubMed ID: 17157329 [TBL] [Abstract][Full Text] [Related]
20. Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin. Cadoret A; Ovejero C; Saadi-Kheddouci S; Souil E; Fabre M; Romagnolo B; Kahn A; Perret C Cancer Res; 2001 Apr; 61(8):3245-9. PubMed ID: 11309273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]